Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Nanocarriers improve skin disease treatment by targeting hair follicles effectively.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

The new biodegradable nanocarriers safely and effectively deliver drugs into the skin.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The inhibitor affects androgen metabolism but not ovarian function.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

The drug showed promise in treating renal cell carcinoma with manageable side effects.